IL200926A0 - Modified release formulations of (6r)-4,5,6,7-tetrahydro-n6-propyl-2,6-benzothiazole-diamine and methods of using the same - Google Patents

Modified release formulations of (6r)-4,5,6,7-tetrahydro-n6-propyl-2,6-benzothiazole-diamine and methods of using the same

Info

Publication number
IL200926A0
IL200926A0 IL200926A IL20092609A IL200926A0 IL 200926 A0 IL200926 A0 IL 200926A0 IL 200926 A IL200926 A IL 200926A IL 20092609 A IL20092609 A IL 20092609A IL 200926 A0 IL200926 A0 IL 200926A0
Authority
IL
Israel
Prior art keywords
benzothiazole
tetrahydro
diamine
propyl
methods
Prior art date
Application number
IL200926A
Original Assignee
Knopp Neurosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/957,157 external-priority patent/US8518926B2/en
Priority claimed from PCT/US2008/057059 external-priority patent/WO2008113003A1/en
Application filed by Knopp Neurosciences Inc filed Critical Knopp Neurosciences Inc
Publication of IL200926A0 publication Critical patent/IL200926A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
IL200926A 2007-03-14 2009-09-14 Modified release formulations of (6r)-4,5,6,7-tetrahydro-n6-propyl-2,6-benzothiazole-diamine and methods of using the same IL200926A0 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US89482907P 2007-03-14 2007-03-14
US89479907P 2007-03-14 2007-03-14
US89481407P 2007-03-14 2007-03-14
US89483507P 2007-03-14 2007-03-14
US97904907P 2007-10-10 2007-10-10
US11/957,157 US8518926B2 (en) 2006-04-10 2007-12-14 Compositions and methods of using (R)-pramipexole
PCT/US2008/057059 WO2008113003A1 (en) 2007-03-14 2008-03-14 Modified release formulations of (6r)-4,5,6,7-tetrahydro-n6-propyl-2,6-benzothiazole-diamine and methods of using the same

Publications (1)

Publication Number Publication Date
IL200926A0 true IL200926A0 (en) 2010-05-17

Family

ID=40382784

Family Applications (1)

Application Number Title Priority Date Filing Date
IL200926A IL200926A0 (en) 2007-03-14 2009-09-14 Modified release formulations of (6r)-4,5,6,7-tetrahydro-n6-propyl-2,6-benzothiazole-diamine and methods of using the same

Country Status (1)

Country Link
IL (1) IL200926A0 (en)

Similar Documents

Publication Publication Date Title
EP2136638A4 (en) Modified release formulations of (6r)-4,5,6,7-tetrahydro-n6-propyl-2,6-benzothiazole-diamine and methods of using the same
HRP20190378T1 (en) Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same
EP2043647A4 (en) Controlled release formulations and associated methods
HK1218427A1 (en) Improved vaccines and methods for using the same
EP2066350A4 (en) Stabilized antibody formulations and uses thereof
AU2013201592A1 (en) Improved vaccines and methods for using the same
GB2443287B (en) Methods, compositions and formulations for the treatment of thyroid eye disease
IL214183A (en) Pharma-informatics system and method, composition for use therewith and method of preparing the composition
ZA200802602B (en) Controlled release formulation
IL199006A0 (en) Nanoparticulate formulations and methods for the making and use thereof
EP2152304A4 (en) Nanoemulsion therapeutic compositions and methods of using the same
HK1213814A1 (en) Diclofenac formulations and methods of use
ZA200808431B (en) Fungicidal compositions and methods of using the same
EP1877068A4 (en) Nicotinamide riboside kinase compositions and methods for using the same
PL2057153T3 (en) (3-aryl-piperazin-1-yl) derivatives of 6,7-dialkoxyquinazoline, 6,7- dialkoxyphtalazine and 6,7-dialkoxyisoquinoline
IL195528A (en) Pyridazine compound, methods for its preparation, pharmaceutical composition comprising the same, use thereof and intermediate
EP2086317A4 (en) Nicotine formulations, kits and systems and methods for their use
HK1131140A1 (en) Substituted prolinamides, and the use thereof
EP2018101A4 (en) Silicone surfactant-based agricultural formulations and methods for the use therof
IL184834A0 (en) Compositions and methods for the manufacture thereof
IL185723A0 (en) Controlled release pharmaceutical compositions of liothyronine and methods of making and using the same
ZA200903049B (en) Polymer-linked-bisphosphonate inhalant formulations and methods for using the same
IL177328A0 (en) Controlled release formulations
IL201959A0 (en) Pyrazolone derivatives, compositions comprising the same and uses thereof
ZA200805711B (en) Solid biocidal compositions and methods of using the same